Showing results (41-50 of 104) with videos related to
Sort By:
Pageof 11
Advanced Materials (Deerfield Beach, Fla.)|April 24, 2018
Mechanobiological Mimicry of Helper T Lymphocytes to Evaluate Cell-Biomaterials CrosstalkMohammad Mahdi Hasani-Sadrabadi, Fatemeh S Majedi, Steven J Bensinger, et al.Plos One|June 7, 2013
Doxycycline alters metabolism and proliferation of human cell linesEthan Ahler, William J Sullivan, Ashley Cass, et al.Cancer Research|February 27, 2013
An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicityKevin J Williams, Joseph P Argus, Yue Zhu, et al.Journal of Thrombosis and Thrombolysis|August 22, 2019
Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settingsTakanori Ikeda, Satoshi Ogawa, Takanari Kitazono, et al.Cerebrovascular Diseases (Basel, Switzerland)|October 3, 2019
Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic AttackKazuo Minematsu, Takanori Ikeda, Satoshi Ogawa, et al.Journal of Cardiology|August 3, 2019
Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal functionJyoji Nakagawara, Takanori Ikeda, Satoshi Ogawa, et al.Heart and Vessels|April 8, 2020
Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillationYuji Murakawa, Takanori Ikeda, Satoshi Ogawa, et al.The Journal of Biological Chemistry|July 6, 2016
Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell DivisionAnkur A Gholkar, Keith Cheung, Kevin J Williams, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 28, 2020
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in JapanSusumu Miyamoto, Takanori Ikeda, Satoshi Ogawa, et al.Heart and Vessels|September 8, 2019
Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillationTakanari Kitazono, Takanori Ikeda, Satoshi Ogawa, et al.Pageof 11